Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-016481
Filing Date
2010-03-30
Accepted
2010-03-30 10:06:49
Documents
11
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 v178955_10k.htm 10-K 2199607
2 GRAPHIC footer.jpg GRAPHIC 5158
3 GRAPHIC logo.jpg GRAPHIC 5965
4 GRAPHIC pg11-1.jpg GRAPHIC 41799
5 GRAPHIC pg11-2.jpg GRAPHIC 34663
6 GRAPHIC pg14.jpg GRAPHIC 88544
7 GRAPHIC pg5.jpg GRAPHIC 28300
8 GRAPHIC sig.jpg GRAPHIC 1741
9 v178955_ex31-1.htm EX-31.1 12484
10 v178955_ex31-2.htm EX-31.2 12425
11 v178955_ex32-1.htm EX-32.1 11411
  Complete submission text file 0001144204-10-016481.txt   2522575
Mailing Address 243 CRANFIELD GREEN SE CALGARY A0 T3M 1C4
Business Address 243 CRANFIELD GREEN SE CALGARY A0 T3M 1C4 403-370-1176
Kun Run Biotechnology, Inc. (Filer) CIK: 0001393526 (see all company filings)

EIN.: 980517550 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-53621 | Film No.: 10712427
SIC: 2834 Pharmaceutical Preparations